ATE122890T1 - In der humantherapie nützliche substanzen peptidischer natur. - Google Patents

In der humantherapie nützliche substanzen peptidischer natur.

Info

Publication number
ATE122890T1
ATE122890T1 AT92900285T AT92900285T ATE122890T1 AT E122890 T1 ATE122890 T1 AT E122890T1 AT 92900285 T AT92900285 T AT 92900285T AT 92900285 T AT92900285 T AT 92900285T AT E122890 T1 ATE122890 T1 AT E122890T1
Authority
AT
Austria
Prior art keywords
substances
administered
humantherapy
peptidic nature
nature useful
Prior art date
Application number
AT92900285T
Other languages
English (en)
Inventor
Alberto Bartorelli
Angela Turiano
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Application granted granted Critical
Publication of ATE122890T1 publication Critical patent/ATE122890T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92900285T 1990-12-11 1991-12-09 In der humantherapie nützliche substanzen peptidischer natur. ATE122890T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.

Publications (1)

Publication Number Publication Date
ATE122890T1 true ATE122890T1 (de) 1995-06-15

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900285T ATE122890T1 (de) 1990-12-11 1991-12-09 In der humantherapie nützliche substanzen peptidischer natur.

Country Status (16)

Country Link
US (1) US5824640A (de)
EP (1) EP0574394B1 (de)
JP (1) JP3213942B2 (de)
KR (1) KR100196028B1 (de)
AT (1) ATE122890T1 (de)
AU (1) AU661287B2 (de)
CA (1) CA2098113C (de)
CZ (1) CZ283037B6 (de)
DE (1) DE69110060T2 (de)
DK (1) DK0574394T3 (de)
ES (1) ES2073277T3 (de)
HU (1) HU217615B (de)
IT (1) IT1244879B (de)
NO (1) NO308396B1 (de)
RU (1) RU2113224C1 (de)
WO (1) WO1992010197A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
DK0928197T3 (da) * 1996-09-18 2003-06-23 Zetesis Spa Anvendelse af proteiner som midler mod autoimmune sygdomme
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
WO2001093894A2 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of parkinson's disease with a protein extractable from mammalian organs
CA2411428A1 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
JPH075476B2 (ja) * 1984-01-12 1995-01-25 ルッシュ、フォルケル ホルモン活性を有する生物学的作用物質、その製法およびヒストンの医薬的用途
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
IT9022341A1 (it) 1992-06-11
CZ111693A3 (en) 1994-04-13
DE69110060D1 (de) 1995-06-29
JPH06504039A (ja) 1994-05-12
NO308396B1 (no) 2000-09-11
IT1244879B (it) 1994-09-12
KR100196028B1 (ko) 1999-06-15
CZ283037B6 (cs) 1997-12-17
HUT64569A (en) 1994-01-28
EP0574394A1 (de) 1993-12-22
CA2098113A1 (en) 1992-06-11
WO1992010197A1 (en) 1992-06-25
HU217615B (hu) 2000-03-28
HU9301677D0 (en) 1993-09-28
AU9035791A (en) 1992-07-08
AU661287B2 (en) 1995-07-20
IT9022341A0 (it) 1990-12-11
US5824640A (en) 1998-10-20
CA2098113C (en) 2002-02-05
NO932101L (no) 1993-08-10
NO932101D0 (no) 1993-06-09
JP3213942B2 (ja) 2001-10-02
DK0574394T3 (da) 1995-10-16
DE69110060T2 (de) 1995-09-28
EP0574394B1 (de) 1995-05-24
ES2073277T3 (es) 1995-08-01
RU2113224C1 (ru) 1998-06-20

Similar Documents

Publication Publication Date Title
ATE122890T1 (de) In der humantherapie nützliche substanzen peptidischer natur.
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
RU95110767A (ru) Днк, кодирующая гликопротеин человеческого происхождения
DK0584266T3 (da) Rekombinant virus udtrykkende carcinoembryonalt antigen og fremgangsmåder til anvendelse heraf
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
DE69034135D1 (de) DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
GR1000477B (el) Νεο μονοκλωνικο αντισωμα κατα νεου αντιγονου που σχετιζεται με ανθρωπινους ογκους.
NL990034I1 (nl) DNA dat codeert voor humane tumor necrosis faktor en humane tumor necrosis faktor polypeptide.
ATE300292T1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
ATE222489T1 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
NZ309659A (en) Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses
NO960309L (no) Agonister og antagonister for humaninterleukin-10
IT8148663A0 (it) Linea di cellule derivate da epato ma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
ES2071833T3 (es) Agente para neutralizar la actividad procoagulante asociada a celulas tumorales.
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
CA2078773A1 (en) Gp75 as a tumor vaccine for melanoma
ES2174103T3 (es) Uso de las secuencias reguladoras de wap o mmtv para expresion dirigida de genes heterologos ligados en celulas mamarias humanas, con inclusion de celulas de carcinoma mamario humano.
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
ES8600518A1 (es) Metodo in vitro para detectar un estado maligno en un paciente humano.
DK0546036T3 (da) Vacciner
EP0136093A3 (de) Antikrebsfaktoren
NO20005321L (no) Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette
DE68911305D1 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee